INMODE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.34 USD | -0.63% |
|
-6.12% | -22.03% |
| Apr. 12 | Barclays Adjusts Price Target on InMode to $33 From $34, Maintains Overweight Rating | MT |
| Apr. 09 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday | MT |
Chart calendar InMode Ltd.
1a68e13.Zu-MIZchJV5bZU-vgHBLHCXU8Ro9EBVwd8fd4thH6fM.NYf2dthucDQdKQnL7EN7X33isFsQXXITMLaO2ox_jIUhhcVtzRlPOCgIdw~3db1de72bd67a13e99c8bba7a34daf6e
Upcoming events on InMode Ltd.
Past events on InMode Ltd.
| 2024-04-09 08:00 am | Needham Healthcare Conference |
| 2024-03-14 | Jefferies Miami MedTech Doctor Summit |
| 2024-03-13 03:05 pm | Barclays Global Healthcare Conference |
| 2024-03-12 08:00 am | Oppenheimer Healthcare MedTech & Services Conference |
| 2024-02-13 08:30 am | Q4 2023 Earnings Call |
| 2024-02-13 07:00 am | Q4 2023 Earnings Release |
| 2023-12-05 | Mizuho Medical Device and Healthcare Services Summit |
| 2023-11-15 | Canaccord MTDF Investor Conference |
| 2023-11-14 03:00 am | Jefferies London Healthcare Conference |
| 2023-11-02 08:30 am | Q3 2023 Earnings Call |
| 2023-11-02 07:00 am | Q3 2023 Earnings Release |
| 2023-09-28 10:55 am | Cantor Global Healthcare Conference |
| 2023-09-27 01:00 pm | Piper Sandler Aesthetics Day |
| 2023-09-12 11:25 am | Baird Global Healthcare Conference |
| 2023-08-15 12:00 pm | UBS Med Device Conference |
| 2023-08-13 | Needham Virtual MedTech & Diagnostics Conference |
| 2023-08-09 12:30 pm | Canaccord Genuity Growth Conference |
| 2023-07-27 08:30 am | Q2 2023 Earnings Call |
| 2023-07-27 07:00 am | Q2 2023 Earnings Release |
| 2023-06-07 01:00 pm | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 156 152 2.97% | 206 202 2.19% | 358 352 1.57% | 454 451 0.67% | 492 490 0.4% | 492 |
|
EBITDA Million USD | Released Forecast Spread | 59,9 57,7 3.88% | 86,1 81,4 5.75% | 179 173 3.48% | 223 218 2.34% | 220 220 0.08% | 213 |
|
EBIT Million USD | Released Forecast Spread | 59,6 56,8 4.93% | 85,7 76,2 12.47% | 179 167 6.88% | 222 216 2.82% | 219 219 0.14% | 208 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 62,0 58,6 5.89% | 76,1 63,4 20.05% | 168 159 5.55% | 201 191 5.43% | 217 210 3.66% | 222 |
|
Net income Million USD | Released Forecast Spread | 61,1 57,2 6.82% | 75,0 67,2 11.64% | 165 156 5.53% | 162 172 -5.84% | 198 188 5.15% | 199 |
|
EPS USD | Released Forecast Spread | 0,80 0,76 5.25% | 0,89 0,80 10.9% | 1,92 1,83 5.21% | 1,89 2,02 -6.44% | 2,30 2,23 3.36% | 2,31 |
| Announcement Date | 18/02/20 | 10/02/21 | 10/02/22 | 14/02/23 | 13/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 111 105 5.27% | 85,9 83,5 2.96% | 114 103 10.1% | 121 116 4.43% | 134 130 3.03% | 106 103 2.58% | 136 133 2.67% | 123 127 -3.15% | 127 125 1.55% | 91,4 | 125 | 133 | 142 | 111 |
|
EBITDA Million USD | Released Forecast Spread | 56,6 50,6 11.93% | 38,2 34,8 9.88% | 55,7 48,9 13.86% | 61,8 55,8 10.63% | 67,3 62,2 8.18% | 45,4 43,2 5.05% | 63,7 61,1 4.33% | 53,1 57,4 -7.53% | 57,7 57,5 0.32% | 35,6 | 54,3 | 59,4 | 63,5 | 45,2 |
|
EBIT Million USD | Released Forecast Spread | 56,5 47,2 19.69% | 38,1 34,6 9.98% | 55,6 47,3 17.53% | 61,6 57,1 7.81% | 67,0 61,8 8.48% | 45,2 43,6 3.79% | 63,5 60,8 4.49% | 53,0 57,1 -7.3% | 57,6 57,3 0.52% | 34,3 | 53,0 | 58,0 | 62,2 | 45,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 54,3 45,8 18.44% | 35,4 31,9 11.04% | 48,3 44,9 7.62% | 53,9 48,6 10.87% | 63,9 56,4 13.26% | 44,3 40,1 10.5% | 61,5 57,5 6.97% | 51,4 56,4 -8.94% | 60,2 56,7 6.13% | 35,9 | 56,9 | 62,5 | 66,9 | 40,8 |
|
Net income Million USD | Released Forecast Spread | 52,7 44,7 17.94% | 31,0 28,0 10.48% | 44,0 40,0 10.13% | 48,8 49,0 -0.45% | 37,7 47,7 -20.99% | 40,5 36,2 11.77% | 55,7 52,7 5.74% | 46,5 50,4 -7.74% | 55,2 52,5 5.01% | 33,3 | 50,5 | 55,1 | 59,6 | 41,6 |
|
EPS USD | Released Forecast Spread | 0,61 0,52 18.45% | 0,36 0,33 10.77% | 0,52 0,47 11.43% | 0,58 0,54 7.41% | 0,44 0,56 -21.43% | 0,47 0,44 7.43% | 0,65 0,62 4.34% | 0,54 0,59 -7.82% | 0,64 0,61 4.5% | 0,39 | 0,59 | 0,64 | 0,69 | 0,51 |
| Announcement Date | 10/02/22 | 02/05/22 | 28/07/22 | 27/10/22 | 14/02/23 | 02/05/23 | 27/07/23 | 02/11/23 | 13/02/24 | - | - | - | - | - |
More events
Past sector events for InMode Ltd.
| 2024-04-18 04:05 pm | INTUITIVE SURGICAL, INC.: Q1 2024 Earnings Release |
| 2024-04-17 | MEHOW INNOVATIVE LTD.: Q1 2024 Earnings Release |
| 2024-04-17 | XIANGYU MEDICAL CO.,LTD: Q4 2023 Earnings Release |
| 2024-04-11 | BMC MEDICAL CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-28 | EDAN INSTRUMENTS, INC.: Q4 2023 Earnings Release |
| 2024-03-28 01:55 am | STRATEC SE: Q4 2023 Earnings Release |
| 2024-03-27 | QINGDAO HAIER BIOMEDICAL CO.,LTD: Q4 2023 Earnings Release |
| 2024-03-27 | LIFETECH SCIENTIFIC CORPORATION: Q4 2023 Earnings Release |
| 2024-03-27 | MICROPORT SCIENTIFIC CORPORATION: Q4 2023 Earnings Release |
| 2024-03-26 | SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INMD Stock
- Calendar InMode Ltd.
